You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

gsk1070806

Showing 1 - 6 of 6
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dermatitis, Atopic Trial (GSK1070806, Placebo)

Not yet recruiting
  • Dermatitis, Atopic
  • GSK1070806
  • Placebo
  • (no location specified)
Aug 22, 2023

Dermatitis, Atopic Trial in Cypress, Las Vegas (GSK1070806, Placebo)

Recruiting
  • Dermatitis, Atopic
  • GSK1070806
  • Placebo
  • Cypress, California
  • +1 more
Jan 20, 2023

Crohn Disease Trial in Birmingham (GSK1070806, Placebo- sodium chloride)

Completed
  • Crohn Disease
  • GSK1070806
  • Placebo- sodium chloride
  • Birmingham, United Kingdom
    University Hospitals Birmingham NHS Foundation Trust
Apr 27, 2021

Kidney Transplantation (Status Post) Trial in Spain, United Kingdom (GSK1070806, 1) basiliximab 2) mycophenolate mofetil (MMF)

Terminated
Has Results
  • Kidney Transplantation (Status Post)
  • GSK1070806
  • 1) basiliximab 2) mycophenolate mofetil (MMF) OR azathioprine 3) tacrolimus 4) corticosteroids
  • L'Hospitalet de Llobregat, Spain
  • +3 more
Jun 18, 2019

Behcet's Disease Trial in Cambridge (GSK1070806)

Unknown status
  • Behcet's Disease
  • GSK1070806
  • Cambridge, United Kingdom
    Addenbrooke's Hospital, University of Cambridge NHS Foundation T
May 1, 2018

IBD Trial in Cambridge (GSK1070806)

Completed
  • Inflammatory Bowel Diseases
  • GSK1070806
  • Cambridge, United Kingdom
    GSK Investigational Site
Jun 9, 2017